Dr. Vivi Ziv, Analyst Research Laboratories’ CEO, has been invited to join BGN Technologies patent committee, as a representative of the biomedical industry.
BGN Technologies is the technology transfer company of Ben-Gurion University of the Negev, Israel, which is one of Israel’s leading research universities and among the world leaders in many fields.
BGN Technologies, which is responsible for the University’s patent portfolio, initiates, leads and implements collaborations with institutions and companies and world-wide, and attracts strategic partners and investors in the fields of hi-tech, life science, cleantech and more.
BGN Technologies’ patent committee is responsible for determining which of the University’s patents, that are about to complete their provisional patent stage, will continue to be supported by the University.
The combination of Analyst’s decades of experience in the biomedical industry, with Dr. Ziv’s experience of more than 23 years in the pharmaceutical, biotechnology and medical device industries, present unique capabilities of a broad industry overview.
Dr. Ziv, Analyst’s CEO said: “I am extremely honored to join this committee and support the decision-making process of such critical issues. This is in line with Analyst’s and our parent company, Tentamus, on-going commitment to support the industry we service, especially the young, early-stage companies.”
About BGN Technologies
BGN Technologies is the technology company of Ben-Gurion University of the Negev, Israel. The company brings technological innovations from the lab to the market and fosters research collaborations and entrepreneurship among researchers and students. To date, BGN Technologies has established over 100 startup companies in the fields of biotech, hi-tech, and cleantech as well as initiating leading technology hubs, incubators, and accelerators. Over the past decade, it has focused on creating long-term partnerships with multinational corporations such as Deutsche Telekom, Dell-EMC, IBM, PayPal, Cincinnati Children’s Medical Center, Merck, Sigma and Bayer, securing value and growth for Ben-Gurion University as well as for the Negev region. For more information, visit the BGN Technologies website.
About Analyst Research Laboratories
Analyst Research Laboratories is a GMP, GLP and GCLP accredited, FDA-inspected contract lab. The 1,000sqm modern lab specializes in all aspects of analysis of pharmaceuticals, providing a multitude of Analytical & Bioanalytical services to the pharmaceutical, medical cannabis, biotech and medical device industries. Please visit Analyst’s website for further information at https://www.analyst-labs.com
BGN Technologies is the technology transfer company of Ben-Gurion University of the Negev, Israel, which is one of Israel’s leading research universities and among the world leaders in many fields.
BGN Technologies, which is responsible for the University’s patent portfolio, initiates, leads and implements collaborations with institutions and companies and world-wide, and attracts strategic partners and investors in the fields of hi-tech, life science, cleantech and more.
BGN Technologies’ patent committee is responsible for determining which of the University’s patents, that are about to complete their provisional patent stage, will continue to be supported by the University.
The combination of Analyst’s decades of experience in the biomedical industry, with Dr. Ziv’s experience of more than 23 years in the pharmaceutical, biotechnology and medical device industries, present unique capabilities of a broad industry overview.
Dr. Ziv, Analyst’s CEO said: “I am extremely honored to join this committee and support the decision-making process of such critical issues. This is in line with Analyst’s and our parent company, Tentamus, on-going commitment to support the industry we service, especially the young, early-stage companies.”
About BGN Technologies
BGN Technologies is the technology company of Ben-Gurion University of the Negev, Israel. The company brings technological innovations from the lab to the market and fosters research collaborations and entrepreneurship among researchers and students. To date, BGN Technologies has established over 100 startup companies in the fields of biotech, hi-tech, and cleantech as well as initiating leading technology hubs, incubators, and accelerators. Over the past decade, it has focused on creating long-term partnerships with multinational corporations such as Deutsche Telekom, Dell-EMC, IBM, PayPal, Cincinnati Children’s Medical Center, Merck, Sigma and Bayer, securing value and growth for Ben-Gurion University as well as for the Negev region. For more information, visit the BGN Technologies website.
About Analyst Research Laboratories
Analyst Research Laboratories is a GMP, GLP and GCLP accredited, FDA-inspected contract lab. The 1,000sqm modern lab specializes in all aspects of analysis of pharmaceuticals, providing a multitude of Analytical & Bioanalytical services to the pharmaceutical, medical cannabis, biotech and medical device industries. Please visit Analyst’s website for further information at https://www.analyst-labs.com
